Sulpiride: Difference between revisions
| Line 35: | Line 35: | ||
|- | |- | ||
!style="text-align: left"| | !style="text-align: left"| | ||
Schizophrenia with predominantly negative | Schizophrenia with predominantly negative | ||
symptoms(flattening of affect, poverty of | |||
symptoms(flattening of affect, poverty of | |||
speech, apathy, as well as depression) | speech, apathy, as well as depression) | ||
|By ''mouth | |By ''mouth | ||
| Line 48: | Line 50: | ||
!style="text-align: left"| | !style="text-align: left"| | ||
Schizophrenia with mainly positive | Schizophrenia with mainly positive | ||
symptoms(hallucinations, delusions, | symptoms(hallucinations, delusions, | ||
incongruity of speech) Respond to higher doses | incongruity of speech) Respond to higher doses | ||
|By ''mouth | |By ''mouth | ||
Revision as of 23:01, 26 October 2020
Drug Class: Antipsychotics, typical ; Antipsychotics, 1st Generation Sulpiride (中文:[[ ]])is a typical antipsychotic or 1st Generation antipsychotic medication. It is used in the treatment of psychosis associated with schizophrenia and major depressive disorder. In low dosage, it is used for anxiety and mild depression.
Pronunciation
Sulpiride 200mg
Sulpiride 50mg
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Sulpiride Cap 50 mg | SULP19 | P1S1S3 |
| Sulpiride Tab 200 mg | SULP20 | P1S1S3 |
Mechanism of Action
Sulpiride is a selective antagonist at dopamine D2, D3 and 5-HT1A receptors. The presumed effectiveness of antipsychotic drugs relied on their ability to block dopamine receptors. This assumption arose from the dopamine hypothesis that maintains that both schizophrenia and bipolar disorder are a result of excessive dopamine activity.
Dosage
| Indication | Dose |
|---|---|
|
Schizophrenia with predominantly negative symptoms(flattening of affect, poverty of speech, apathy, as well as depression) |
By mouth
ADULT:
ELDERLY or debilitated patients:
|
|
Schizophrenia with mainly positive symptoms(hallucinations, delusions, incongruity of speech) Respond to higher doses |
By mouth
ADULT:
ELDERLY or debilitated patients:
|
